Vijaya Diagnostic Centre Ltd. · NSE:VIJAYA
Vijaya Diagnostic Centre — Q3 FY26 Earnings Presentation
45 slides from Vijaya Diagnostic Centre's earnings presentation, Feb 13, 2026
Slide 1: Cover letter to stock exchanges
February 13, 2026 To To The Listing Department, The Corporate Relations Department, National Stock Exchange of India Limited BSE Limited NSE Symbol: VIJAYA BSE Scrip Code: 543350 Dear Sir/Madam, Sub: Investor Presentation Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure Requi
Slide 2: Q3 & 9M FY26 Earnings Presentation
Q3 & 9M FY26 Earnings Presentation February 13, 2026 Q2 & H1 FY25 Earnings Presentation, November 07, 2024
Slide 3: Safe Harbour
Safe Harbour This presentation and the accompanying slides (the “Presentation”), which have been prepared by Vijaya Diagnostic Centre Limited (the ‘Company’), have been prepared solely for information purposes and do not constitute any offer, recommendation or invitation to purchase or subscribe for
Slide 4: Disclaimer
Disclaimer Disclaimer Note 1: Merger (Medinova Diagnostic Services Limited, Kolkata) : Pursuant to the NCLT, Hyderabad Bench order dated 13 October 2025, Medinova Diagnostic Services Limited got merged with the Company effective 01 April 2024. Accordingly, the financial numbers for the current perio
Slide 5: Q3 FY26 Performance Snapshot
Q3 FY26 Performance Snapshot Strategic Expansion
Slide 6: Q3 FY26 Performance Snapshot
Q3 FY26 Performance Snapshot Financial Performance Key Metrics 1.17 Mn 4.22 Mn INR 2,052 Mn Footfall Tests Revenue from Operations INR 861 Mn | 41.9% INR 432 Mn | 21.0% 162 (1) 92% EBITDA | EBITDA Margin % PAT | PAT Margin % Centres B2C Revenue % YOY Growth % Geographical Contribution Wellness Share
Slide 7: 9M FY26 Performance Snapshot
9M FY26 Performance Snapshot Financial Performance Key Metrics 3.47 Mn 12.44 Mn INR 5,948 Mn Footfall Tests Revenue from Operations INR 2,414 Mn | 40.6% INR 1,251 Mn | 21.0% 162 (1) 92% EBITDA | EBITDA Margin % PAT | PAT Margin % Centres B2C Revenue % YOY Growth % Geographical Contribution Wellness
Slide 8: Management Commentary
Management Commentary “ Vijaya reported a robust Q3 FY26 delivering a strong revenue growth of ~21.4%, supported by volume growth of nearly ~15%. Importantly, revenues also surpassed Q2 in absolute terms, a notable achievement considering Q3 is traditionally impacted by festive and seasonal softness
Slide 9: Key Financial Highlights – Q3 FY26 & 9M FY26
Key Financial Highlights – Q3 FY26 & 9M FY26 Revenue from Operations (INR Mn) EBITDA & EBITDA Margin % PAT & PAT Margin % 39.7% 40.6% 41.9% 40.2% 40.6% 20.9% 21.5% 21.0% 21.4% 21.0% 5,948 5,081 Key 2,414 2,052 2,044 1,250 Financials 2,016 1,089 1,690 671 818 861 433 432 353 Q3 FY25 Q2 FY26 Q3 FY26 9
Slide 10: Key Operational Highlights
Key Operational Highlights Tests Performed (# in Mn) Footfalls (# in Mn) Tests / Footfalls (#) 12.44 3.47 3.14 3.61 11.00 3.59 3.57 4.28 1.20 1.17 3.52 3.68 4.22 1.05 3.50 Q3 FY25 Q2 FY26 Q3 FY26 9M FY25 9M FY26 Q3 FY25 Q2 FY26 Q3 FY26 9M FY25 9M FY26 Q3 FY25 Q2 FY26 Q3 FY26 9M FY25 9M FY26 Revenue
Slide 11: Consolidated Profit & Loss Statement
Consolidated Profit & Loss Statement (INR Mn) Particulars Q3 FY26 Q3 FY25 Y-o-Y Q2 FY26 Q-o-Q 9MFY26 9MFY25 Y-o-Y FY25 FY24 Y-o-Y Revenue from operations 2,052.1 1,689.8 21.4% 2,015.6 1.8% 5,948.3 5,081.5 17.1% 6,813.9 5,478.1 24.4% Cost of materials consumed 240.3 208.5 15.2% 243.2 -1.2% 697.6 626.
Slide 12: Key Developments
Key Developments Strategic Expansion
Slide 13: Strengthening Senior Leadership Team for the Next Leg of Growth
1 Strengthening Senior Leadership Team for the Next Leg of Growth Chief Financial Officer (CFO) Chief Technology Officer (CTO) Ankit Shah Sai Prasad Total Experience: 20+ years Total Experience: 20+ years Last Experience: Chief Financial Officer - Last Experience: Director Software INCOR Group (Omni
Slide 14: Inaugurated a state-of-the-art Hub in Phoolbagan, West Bengal
2 Inaugurated a state-of-the-art Hub in Phoolbagan, West Bengal Inaugurated State-of-the-Art Hub in Phoolbagan in the 2nd week of Dec-25 in line with our strategy of creating dense network in WB Phoolbagan Serves as major transit hub Facility houses with densely population advanced equipment featuri
Slide 15: Inaugurated a state-of-the-art Hub in Diamond Harbour, West Bengal
3 Inaugurated a state-of-the-art Hub in Diamond Harbour, West Bengal Inaugurated State-of-the-Art Hub in Diamond Harbour in the 2nd week of Dec-25 in line with our strategy of creating dense network in WB Kasba 5,250+ sq. ft. facility The urban area is densely houses advanced populated, featuring se
Slide 16: Inaugurated a state-of-the-art Hub in Nandyal, AP
4 Inaugurated a state-of-the-art Hub in Nandyal, AP Inaugurated State-of-the-Art Hub in Nandyal in the 1st week of Oct-25 in line with our strategy of broadening presence in tier 2 / 3 geographies of our core markets Nandyal 8,000 sq.f.t facility houses Vijaya already has an automated lab & establis
Slide 17: Inaugurated a state-of-the-art Hub in Khammam, Telangana
5 Inaugurated a state-of-the-art Hub in Khammam, Telangana Inaugurated State-of-the-Art Hub in Khammam in the 4th week of Oct-25 in line with our strategy of broadening presence in tier 2 / 3 geographies of our core markets Khammam 10,000+ sq.f.t facility Marks our entry houses an automated lab into
Slide 18: Strategic Expansion
Strategic Expansion Strategic Expansion
Slide 19: Expanding Strategically in Alignment with our Vision
Expanding Strategically in Alignment with our Vision Inorganic Expansion Strategy • Successfully acquired PH, Pune's largest B2C integrated diagnostic chain • This strategic acquisition seamlessly aligns East India Strategy with our commitment to providing top-notch healthcare services at affordable
Slide 20: Expansion Plans - Upcoming Hubs and Spokes Centres
Expansion Plans - Upcoming Hubs and Spokes Centres Tentative Timelines for Geography Count & Type Commencement Hyderabad 1 Spoke H2 FY26 5 Spokes H1 FY27 RoAPT H1 FY27 3 Spokes H1 FY27 1 10 1 Hub Hub Spokes Bengaluru H1 FY27 1 Spoke 1 Spoke H1 FY27 West Bengal 19
Slide 21: Company Overview
Company Overview Strategic Expansion
Slide 22: Vijaya at a Glance
Vijaya at a Glance Vijaya Diagnostic is the largest integrated B2C focused diagnostic chain in India with 162 state-of-the-art centres spread across 27 cities & towns Evolved from a regional player to a player with presence in multiple geographies … … While retaining its core values of providing Qua
Slide 23: Our Journey
Our Journey 1981 1993 1995 2007 20032012 2005 2016 ▪ Vijaya Diagnostic Centre ▪ Became 1st independent diagnostic ▪ Recognized as one of the Best ▪ Received investment from incorporated in Hyderabad centre in South India to offer PET CT Imaging centres in Hyderabad Karakoram Limited & Kedaara from W
Slide 24: Integrated Diagnostics Player Offering One-Stop Solution
Integrated Diagnostics Player Offering One-Stop Solution Complete Range of Diagnostic Services under One Roof Robust operational network enables us to offer integrated, high-quality diagnostic services that significantly elevate the customer experience 37.1 62.9 % Pathology (1) % Radiology (1) 23 1.
Slide 25: Dominant Position in Telangana & AP Markets with a Strong Brand Recall
Dominant Position in Telangana & AP Markets with a Strong Brand Recall … Vijaya has been successful in creating a dense market consolidating its foothold in its core geographies of AP & Telangana markets Present in Key Geographies of AP & Telangana 69 (1) % Hyderabad Revenue Contribution Nizamabad M
Slide 26: Driving Geographical Diversification through Strategic Expansion
… and Driving Geographical Diversification through Strategic Expansion Gurgaon Hyderabad Pune RoAPT West Bengal Kalaburagi Bengaluru 72% 78% 68% 68% 19% 19% 18% 17% Geographical 6% 6% 6% 7% 7% Revenue Mix 2% 4% 3% Q3 FY26 Q2 FY26 FY25 FY24 Q3 FY26 Q2 FY26 FY25 FY24 Q3 FY26 Q2 FY26 FY25 FY24 Q3 FY26
Slide 27: Boosting Accessibility with Best-in-class Online Services & Home Collections
Boosting Accessibility with Best-in-class Online Services & Home Collections Online Services Home Collections Enhancing Customer Experience through Seamless Online App, E-Commerce Website and Call Centre Bookings Elevating Customer Experience through Home Collections Access to reports online & histo
Slide 28: Robust Technical Capabilities with State-of-the-art IT Infrastructure
Robust Technical Capabilities with State-of-the-art IT Infrastructure 41 9 Advanced Software to Manage Clinical Data CT Machines PET CT / Gamma machines 43 300+ MRI Machines Fully Integrated Radiology Radiologists, Lab Doctors & Advance Laboratory Information Systems (RIS) and Physicians Information
Slide 29: Experienced Board of Directors
Experienced Board of Directors Ms. Suprita Reddy Dr. S. Surendranath Reddy Mr. Sunil Chandra Kondapally S Geeta Reddy Managing Director & Chief Founder & Exec. Chairman Executive Director Non-Executive Director Executive Officer ✔ 40+ years of experience ✔ 22+ years of experience ✔ 35+ years of expe
Slide 30: Shareholding Pattern as at 31st December, 2025
Shareholding Pattern as at 31st December, 2025 Shareholding Pattern as at 31st December, 2025 Others 4.3% FIIs 15.1% Promoter & Promoter Group 52.6% DIIs 28.0% DIIs: Mutual Funds, AIFs and QIBs FIIs: Hedge Funds, Sovereign Wealth Funds, Foreign MFs, Pension Funds, Trusts and AMCs Others: Retail, Bod
Slide 31: Doctors Connect Program in Q3 FY26
Doctors Connect Program in Q3 FY26 30
Slide 32: Awards & Accolades
Awards & Accolades Icon in Integrated Diagnostic Best Diagnostic Centre Icon in Integrated Diagnostic Most Trusted Brand of India Services by Times Health awarded at HMTV Healthcare Services by Times Health 2024-25 awarded by Best Healthcare Brands’ 2025 Excellence TS & AP 2025 Awards 2025 Excellenc
Slide 33: Annexure
Annexure Strategic Expansion
Slide 34: State-of-the-art Infrastructure (1/3)
State-of-the-art Infrastructure (1/3) 33
Slide 35: State-of-the-art Infrastructure (2/3)
State-of-the-art Infrastructure (2/3) 34
Slide 36: State-of-the-art Infrastructure (3/3)
State-of-the-art Infrastructure (3/3) 35
Slide 37: Advanced Equipment in Place to Deliver High Quality Services (1/2)
Advanced Equipment in Place to Deliver High Quality Services (1/2) 36
Slide 38: Advanced Equipment in Place to Deliver High Quality Services (2/2)
Advanced Equipment in Place to Deliver High Quality Services (2/2) 37
Slide 39: Robust Operational Metrics
Robust Operational Metrics Diagnostic Centre (Nos) Footfalls (Mn) Tests Performed (Mn) 4.19 145 151 3.62 3.55 14.79 121 3.18 11.89 95 2.63 10.05 9.32 80 7.09 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 Test per Footfall (Nos) Revenue per Test (INR) Revenue per Footfall
Slide 40: Consistent Financial Performance
Consistent Financial Performance (INR Mn) Revenue EBIDTA PAT CAGR:16.0% CAGR:13.3% CAGR:14.2% 6,814 2,732 5,478 2,037 2,209 1,438 4,624 4,592 1,660 1,820 1,097 1,188 3,767 845 846 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 EBIDTA Margin (%) PAT Margin (%) 22.4% 23.7%
Slide 41: Sustainable Cash Generation & Increasing Return Ratios
Sustainable Cash Generation & Increasing Return Ratios Surplus Cash CFO (1) / EBIDTA (%) (INR Mn) 2,465 2,554 90% 2,277 2,067 1,851 83% 82% 78% 78% FY21 FY22 FY23 FY24 FY25 FY21 FY22 FY23 FY24 FY25 RoCE Pre-Tax (2) (%) RoE (%) 32% 31% 23% 23% 25% 25% 18% 18% 22% 16% FY21 FY22 FY23 FY24 FY25 FY21 FY2
Slide 42: Consolidated Profit & Loss Account
Consolidated Profit & Loss Account (INR Mn) Particulars FY21 FY22 FY23 FY24 FY25 Revenue from operations 3,767 4,624 4,592 5,478 6,814 Cost of materials consumed 571 715 589 654 848 Employee benefits expense 574 707 785 902 1,122 Other expenses 962 1,165 1,398 1,712 2,113 EBITDA 1,660 2,037 1,820 2,
Slide 43: Consolidated Balance Sheet
Consolidated Balance Sheet (INR Mn) Assets Mar-21 Mar-22 Mar-23 Mar-24 Mar-25 Equity & Liabilities Mar-21 Mar-22 Mar-23 Mar-24 Mar-25 NON-CURRENT ASSETS 3,022 4,436 5,777 7,714 9,664 EQUITY 3,592 4,695 5,466 6,599 7,991 Property, plant and equipment 1,358 1,966 2,940 3,785 4,469 Equity share capital
Slide 44: Consolidated Cash Flow Statement
Consolidated Cash Flow Statement (INR Mn) Particulars Mar-21 Mar-22 Mar-23 Mar-24 Mar-25 Cash Flow from Operating Activities Profit before Tax 1,121 1,474 1,135 1,587 1,932 Adjustment for Non-Operating Items 534 572 683 599 786 Operating Profit before Working Capital Changes 1,655 2,046 1,818 2,186
Slide 45: Thank You
Thank You For further information please contact: Mr. Dhiren Gala AGM - Strategy & Investor Relations +91 90598 93206 dhiren.g@vijayadiagnostic.in ir@vijayadiagnostic.in www.vijayadiagnostic.com Corporate Office : #6-3-883/F, FPA Building, Near Topaz Building, Punjagutta, Hyderabad-500082, Telangana
Vijaya Diagnostic Centre — Q3 FY26 Earnings Presentation on 6ix